Women’s health groups, including the American College of Obstetricians and Gynecologists, sued the U.S. Food and Drug Administration to allow patients to receive a prescribed abortion pill by mail rather than only in person at a hospital, clinic or doctor’s office.
The restriction on mail distribution of the drug, mifepristone, is unnecessary and only increases health risks for patients during the Covid-19 pandemic, the groups said in their lawsuit, according to the American Civil Liberties Union, which filed the case Wednesday in Maryland federal court.
The suit joins others the ACLU has filed to fight abortion restrictions since the spread ...